1[1]Palleroni NJ, Bradbury JF. Stenotrophomonas, new bacterial genus for xanthomonas maltophilia (Hugh 1989)swings et al. 1983, Int J Syst Bacteriol 1993; 43:606 被引量：1
2[2]Davin-Regli A, Bollet C, Auffrav JP, et al. Use of random amplified polymorphic DNA for epidemiological typing of stenotrophomonas maltophilia. J Hosp Infect 1996; 32(1): 39 被引量：1
3[3]Von Graevenitz A. Acinetobacter, Alcaliyenes, Moraxella and other nonfermentative Gram negative bacteria. In:Murry PR (ed.). Manual of Clinical Microbiology. 6th ed.Washington DC: American Society for Microbiology 1995:520 被引量：1
4[5]Spencer RC. The emergence of epidemic multiple antibiotic resistant Stenotrophomonas (Xanthomonas) meltophilia and Burkholderia (Pseudomonas) cepacia. J Hosp Infect 1995; 30 (Supp): 453 被引量：1
5[6]Villarino ME, Stevens LE, Schable B, et al. Risk factors for epidemic xanthomonas maltophila infection/colonization in intensive care unit patients. Infect control Hosp Epidemiol 1992; 13:201 被引量：1
6[7]Klausner JD, Zukerman C, Limaye AP, et al. Outbreak of stenotromonas maltophilia bacteremia among patients undergoing bone marrow transplantation: association with faulty replacement of handwashing soap. Infect control Hosp Epiemiol 1999; 20 (11); 756 被引量：1
8[9]Khardori N, Reuben A, Rosebaum B, et al. In vitro susceptibility of X. maltophlia to newer antimicrobial agent. Antimicrob Agents Chemother 1990; 34:1609 被引量：1
9[10]Davin-Regli A, Bollet C, Auffray JP, et al. Use of radon amplified polymorphic DNA for epidemilogical typing of stenotrophomonas maltophilia. J Hosp Infect 1996; 32(1): 39 被引量：1
10[11]Carmeli Y, Samore MH. Comparison of treatment with imipenem vs ceftazidime as a predisposing factor for nosocomial acquisition of stenotrophomonas maltophilia:A historical cohort study. Clin Infect Dis 1997; 24(6): 1131 被引量：1
